New Ways to Deliver Hydrogen Therapy Show Promise for Cancer and Inflammation
- Authors
- Lam-Duc-Huy Nguyen, Sheng-Yao Peng, Cam-Hoa Mac, Nhien Nguyen, Shih-Kai Lo, Po-Hsi Lin, Ninh-Son Pham, Hsiao-Huang Chang, Yu-Jung Lin, Hsing-Wen Sung
- Journal
- Advanced Drug Delivery Reviews
- Year
- 2025
- DOI
- 10.1016/j.addr.2025.115734
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Taiwan
- Health Condition
- Cancer
- Body System
- Immune System
TL;DR
Scientists found that hydrogen gas can fight diseases like cancer and inflammation in your body, but getting it to the right place inside you is tricky—so researchers are developing clever new delivery methods (like using light or sound to release the hydrogen exactly where it's needed) to make hydrogen treatments actually work in real patients.
Key Finding
Advanced hydrogen delivery systems using light-activated, sound-activated, and bacteria-based approaches show promise for overcoming the bioavailability and targeting limitations of conventional hydrogen delivery methods like inhalation and H2-rich water.
Summary
This review examines how molecular hydrogen (H2)—a gas that can act as an antioxidant and reduce inflammation in the body—works as a potential medicine and discusses different ways to deliver it to patients. The authors explain that while H2 shows promise in laboratory and early clinical studies, traditional delivery methods like breathing it in or drinking H2-rich water have problems with stability and effectiveness. The review describes newer delivery approaches, including special carriers that release H2 in response to light or sound, and methods that use gut bacteria to produce H2 naturally.
Practical Takeaway
This is a review article summarizing research directions rather than reporting new experimental results, so it does not provide direct evidence about hydrogen water's effects in humans. While the review suggests emerging delivery technologies may improve how hydrogen reaches target tissues, most supporting evidence comes from laboratory and animal studies. Anyone considering hydrogen water should note that conventional delivery methods (like drinking H2-rich water) remain the most practical current option, though their real-world effectiveness in humans requires further clinical testing.
Abstract
Molecular hydrogen (H2) has emerged as a promising therapeutic agent owing to its selective antioxidant and anti-inflammatory properties, as well as its ability to modulate cellular signaling, metabolism, and immune responses. Beyond mitigating oxidative stress and inflammation, H2 shows anticancer potential by altering the tumor microenvironment and inducing apoptosis. Despite encouraging findings from preclinical and clinical studies, conventional delivery routes-such as inhalation, oral intake of H2-rich water, or injection of H2-rich saline-face critical limitations in stability, bioavailability, and targeted delivery, impeding clinical translation. This review first outlines the therapeutic mechanisms of H2, including redox regulation, inflammatory modulation, and tumor suppression. It then discusses current delivery approaches, their therapeutic outcomes, and inherent challenges. To overcome these barriers, a variety of advanced H2-delivering systems have been developed, including H2-containing carriers and in situ H2-generating materials based on water-, acid-, and electrochemical reactions. Externally stimulated platforms, such as photo-, sono-, and electro-catalysis-based systems, enable spatiotemporally controlled H2 release in response to disease-specific cues. Additionally, microbiota-targeted approaches involving probiotics and prebiotics offer indirect yet sustained H2 delivery via gut fermentation. The review concludes by addressing key challenges-such as material scalability, biosafety, and integration with existing therapies-and highlights future directions for optimizing H2 delivery through interdisciplinary innovation in materials science and medicine.